XtalPi Holdings Ltd
2228
Rang in aandelen
#4646
XtalPi Holdings Limited functions as an investment holding company, delivering... XtalPi Holdings Limited functions as an investment holding company, delivering sophisticated drug discovery and intelligent automation solutions across key markets including China, the United States, Europe, South Korea, and Japan. Its comprehensive drug discovery services encompass the entire research and development process, ranging from target validation and hit identification to lead generation, lead optimization, and PCC nomination. These services are adept across diverse therapeutic modalities, such as small molecules, antibodies, peptides, ADCs, and PROTACs. The company's intelligent automation solutions specifically utilize artificial intelligence and automation to facilitate the accelerated discovery and research of novel drugs and materials. Established in 2015 and based in Shenzhen, China, the firm was formerly known as QuantumPharm Inc. before officially changing its name to XtalPi Holdings Limited in December 2024.
Aandeelprijs
$0.74616501
Marktkapitalisatie
$3.21B
Verandering (1 dag)
-4.10%
Verandering (1 jaar)
-50.36%
Land
CN
Handel XtalPi Holdings Ltd (2228)
Categorie
Healthcare
P/B-ratio voor XtalPi Holdings Ltd (2228)
P/B-ratio op October 2026 TTM: 2.26
Volgens de meest recente financiële rapporten en aandelenkoers van XtalPi Holdings Ltd is de huidige P/B-ratio (TTM) 2.26. Eind 2024 had het bedrijf een P/B-ratio van 2.72.
P/B-ratiohistoriek voor XtalPi Holdings Ltd van 2024 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 2.26 | -33.91% |
| 2025 | 3.42 | 25.85% |
| 2024 | 2.72 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| 6.251 | 176.56% |
US
|
|
| 13.2547 | 486.41% |
US
|
|
| 4.4521 | 96.97% |
AU
|
|
| 6.3632 | 181.52% |
NL
|
|
| - | - |
CH
|
